The effects of atorvastatin in mustard gas exposed patients with chronic obstructive pulmonary disease: A randomized controlled trail

H. Ghobadi, S. M. Lari, F. Pourfarzi, A. Mahmoudpour, M. Ghanei (Ardabil, Mashad, Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2012 - COPD beyond tobacco
Session: COPD beyond tobacco
Session type: Thematic Poster Session
Number: 4009
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Ghobadi, S. M. Lari, F. Pourfarzi, A. Mahmoudpour, M. Ghanei (Ardabil, Mashad, Tehran, Islamic Republic Of Iran). The effects of atorvastatin in mustard gas exposed patients with chronic obstructive pulmonary disease: A randomized controlled trail. Eur Respir J 2012; 40: Suppl. 56, 4009

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effects of oral clarithromycin on airway inflammation in moderate to severe chronic obstructive pulmonary disease (COPD) - a double blind randomised controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 338s
Year: 2001

Effects of combined therapy with nebulized b2-agonist and anticholinergic in severe exacerbation of chronic obstructive pulmonary disease. Randomized controlled trial
Source: Eur Respir J 2007; 30: Suppl. 51, 611s
Year: 2007

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial
Source: Eur Respir J 2002; 19: 936-943
Year: 2002



Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial.
Source: Eur Respir J 2002; 20: 245
Year: 2002


Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trial
Source: Eur Respir J, 50 (1) 1601448; 10.1183/13993003.01448-2016
Year: 2017



Effectiveness of the use of heliox on nebulizer associated with noninvasive ventilation in chronic obstructive pulmonary disease patients: A randomized controlled trial
Source: Annual Congress 2012 - Recent technical developments in long-term noninvasive ventilation
Year: 2012

A single centre double-blind placebo controlled pilot study into the use of intravenous magnesium sulphate for the treatment of acute exacerbation of chronic obstructive airways disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004

A randomised controlled trial of the effect of oxygen saturation on attention task performance of chronic obstructive pulmonary disease patients
Source: Eur Respir J 2006; 28: Suppl. 50, 70s
Year: 2006

Effects of continuous chest wall vibration on dyspnoea and exercise tolerance in patients with chronic obstructive pulmonary disease: a randomized controlled trial.
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


Non-invasive positive pressure ventilation (NIPPV)for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 403s
Year: 2003

Heliox and alveolar oxygenation in patients with chronic obstructive pulmonary disease: a multicentre, randomised, crossover study
Source: Eur Respir J 2004; 24: Suppl. 48, 243s
Year: 2004

The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013


A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006

Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial
Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions
Year: 2009


Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
Source: Eur Respir J 2003; 21: 68-73
Year: 2003



Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial
Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019
Year: 2019



Does sildenafil improves exercise capacity and pulmonary artery hypertension in chronic obstructive pulmonary disease? A controlled trial
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009


Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study.
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005